Home > Insider Trading > Filing (0001562180-22-002665)

Filing Details

Accession Number:: 0001562180-22-002665
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-16 11:16:19
Reporting Period:: 2022-03-14

Accepted Time:: 2022-03-16 11:16:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
105770	West Pharmaceutical Services Inc	WST	Fabricated Rubber Products, Nec (3060)	231210010

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1744326	J Quintin Lai	530 Herman O. West Drive Exton PA 19341	Vp Corp Development & Strategy	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-03-14	2,440	$94.27	7,812	No	4	M	Direct
Common Stock	Acquisiton	2022-03-14	5,576	$83.47	13,388	No	4	M	Direct
Common Stock	Disposition	2022-03-14	1,271	$367.12	12,117	No	4	S	Direct
Common Stock	Disposition	2022-03-14	405	$367.94	11,712	No	4	S	Direct
Common Stock	Disposition	2022-03-14	1,254	$369.86	10,458	No	4	S	Direct
Common Stock	Disposition	2022-03-14	446	$370.94	10,012	No	4	S	Direct
Common Stock	Disposition	2022-03-14	600	$371.89	9,412	No	4	S	Direct
Common Stock	Disposition	2022-03-14	900	$372.92	8,512	No	4	S	Direct
Common Stock	Disposition	2022-03-14	2,940	$374.45	5,572	No	4	S	Direct
Common Stock	Disposition	2022-03-14	200	$374.92	5,372	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Disposition	2022-03-14	2,440	$0.00	2,440	$94.27
Common Stock	Stock Options (Right to buy)	Disposition	2022-03-14	5,576	$0.00	5,576	$83.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
34,640	2018-02-05	2027-02-05	No	4	M	Direct
29,064	2018-02-21	2027-02-21	No	4	M	Direct

Footnotes

The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $366.50 to $367.42, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $367.56 to $368.22, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $369.40 to $370.36, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.41 to $371.32, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.65 to $372.40, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $372.70 to $373.46, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $373.86 to $374.83, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.